Klaris

Investor: Meridian Health Ventures

Klaris, an innovative AI-powered medtech startup based in London, has successfully closed a pre-seed funding round, raising £730,000. This capital infusion is earmarked to further develop its automated regulatory compliance platform, designed to significantly expedite the approval process for new medical devices by automating technical documentation.Summary of transaction details:Value: £730,000Sector: Health Tech, AI, Regulatory ComplianceAdvisor: Not disclosedKey Entities: Klaris (Target), Meridian Health Ventures (Lead Investor), Antler, Vento Ventures, Alecla7, and angels (Investors)Location: London, UKNote: This funding underscores the growing demand for AI-driven solutions to overcome bureaucratic hurdles in highly regulated industries. By automating complex compliance procedures, Klaris aims to reduce the time and cost associated with bringing essential medical devices to market, addressing a critical bottleneck highlighted by high rates of initial FDA submission rejections.

Investor: Vento Ventures, Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital, Alecla7, University College London Hospitals, Cedars-Sinai Medical Center, Antler, Meridian Health Ventures